Search

Search Constraints

You searched for: Author/Creator Freimer, Miriam

Search Results

1. A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Issue 1 (30th April 2013)

2. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival. (21st December 2020)

4. Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3, 4‐diaminopyridine. Issue 2 (21st December 2015)

5. Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America. Issue 9 (18th September 2020)

6. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021)

7. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021)